The first drug that takes advantage of this natural biological process, called RNA interference, was approved August 10 by the U.S. Food and Drug Administration. It targets a rare hereditary disease that causes misshapen proteins to build up in patients’ nerves, tissues and organs, causing loss of sensation, organ failure and even death.
Ryan Murphy, an economist at Southern Methodist University, recently published a working paper in which he ranked each of the states by the predominance of--there’s no nice way to put it--psychopaths. The winner? Washington in a walk. In fact, the capital scored higher on Murphy’s scale than the next two runners-up combined.
In April, the Congressional Budget Office reported the U.S. annual budget deficit will reach $1 trillion by 2020. That’s a troubling trajectory, but no one in Washington seems to care enough to stop spending money. I only see one answer. Washington needs to spend more money. Spending in one area now might actually help avert a fiscal apocalypse later.
According to research from the Society for Human Resource Management, citing Bureau of Labor Statistics (BLS) data, the percentage of boomers retiring has doubled over the past eight years and will continue to increase until the last of the boomers reach 65 around 2030. This is particularly challenging for manufacturers. Not only are more than a quarter of manufacturing workers over the age of 55, but the BLS also notes that manufacturers have the highest tenure compared to other sectors.
Coffee sellers are mulling how to fight a California judge’s ruling that would require the beverage to be branded with cancer warning labels. The National Coffee Association, whose members include Starbucks and Dunkin’ Donuts, said in a statement on Thursday that it was “currently considering all of its options, including potential appeals and further legal actions.”
Anyone without 20/20 vision can tell you about the struggles of wearing corrective lenses: Contacts often leave eyes tired and dry at the end of the day, and finding the perfect frames for your glasses can be a headache. But now nanotechnology could make it possible to correct vision using eye drops, which would eliminate the need for expensive and annoying eyewear.
Last month, a pair of Apple shareholders demanded in an open letter that the company address growing concerns about children's addiction to their products. In light of research on the detrimental effects of electronic-media use, investment firm JANA Partners and the California State Teachers' Retirement System argued, parents need better resources to make sure children are using devices "in an optimal manner."
New “videomicroscopes” offer astounding images, helping surgeons perform and collaborate on delicate brain and spine operations. The equipment produces magnified, high-resolution, three-dimensional digital images of surgical sites, and lets everyone in the room see exactly what the surgeon is seeing. The videomicroscope has a unique ability to capture “the brilliance and the beauty of the neurosurgical anatomy,” Dr. Langer said.
Makers of just 10 drugs may have shortchanged the nation's Medicaid system by at least $1.3 billion from 2012 through 2016 by misclassifying their products in a rebate program, a government analysis found. The analysis also showed that while nearly 900 drugs may have been misclassified, in 2016 just four drugmakers were responsible for 54 percent of the potential misclassifications that led to the underpayments to the Medicaid Drug Rebate Program
“Overall, it will help manufacturers bring their innovations to market more efficiently by providing a transparent process for future submissions and making sure our regulatory approach is properly tailored to the unique opportunities and challenges posed by this promising new technology,” explained FDA Commissioner Scott Gottlieb, MD.